Recorded fact · drug.trial_access

drug.trial_access for brexpiprazole

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 9cc238ba resolves to.

The record

Fact id	`9cc238ba1de2895dad77e99f`
Entity	drug: brexpiprazole
Field	drug.trial_access
Source	clinicaltrials.gov
Read on	2026-11-07T06:34:32.466Z
Source version	clinicaltrials-api-2.0.5-data-2026-11-06T10:00:05
Method	api
Verification	machine_read
Licence	Terms and Conditions (last updated 2023-01-31) READ in full 2026-11-07: data free to all requesters; reuse allowed on conditions: attribute ClinicalTrials.gov, keep data current, display the date the registry processed the data, state any modifications; do not represent the data as other than a US Government database; no use of extracted email addresses for marketing; some records may carry third-party copyright (consult the submitter) and the data carry an international copyright outside the US. API rate guidance page UNREAD (JS page rendered no text 2026-11-07). AMBER because of the third-party copyright caveat on submitter text; counts and ids are safe, long free text is not reproduced. \| DISPLAY CONDITIONS (any page or delivery using this source): attribute ClinicalTrials.gov, show the registry processing date, state our modifications, never present as other than a US Government database, never use extracted emails for marketing.
Edition	2026-11, Merkle root `006ab9a329709cbe...`

This fact carries no verifying quote; its source is the dataset named above.

The value

{
 "ingredient": "BREXPIPRAZOLE",
 "recruitingInterventionalCount": 5,
 "notYetRecruitingCount": 2,
 "byPhase": {
  "PHASE3": 2,
  "PHASE1": 1,
  "PHASE4": 1,
  "PHASE2": 1
 },
 "trials": [
  {
   "nctId": "NCT05325645",
   "briefTitle": "Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Otsuka Pharmaceutical Co., Ltd.",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-09-16",
   "startDate": "2022-07-21",
   "conditions": [
    "Acute Schizophrenia"
   ],
   "countries": [
    "Japan"
   ],
   "url": "https://clinicaltrials.gov/study/NCT05325645"
  },
  {
   "nctId": "NCT04569448",
   "briefTitle": "Brexpiprazole Treatment for Bipolar I Depression",
   "phase": [
    "PHASE3"
   ],
   "leadSponsor": "Douglas Mental Health University Institute",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-08-27",
   "startDate": "2021-05-10",
   "conditions": [
    "Bipolar Depression"
   ],
   "countries": [
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04569448"
  },
  {
   "nctId": "NCT06674694",
   "briefTitle": "The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.",
   "phase": [
    "PHASE1"
   ],
   "leadSponsor": "Sichuan Kelun Pharmaceutical Co.,Ltd.",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-06-29",
   "startDate": "2024-04-10",
   "conditions": [
    "Schizophrenia Disorders"
   ],
   "countries": [
    "China"
   ],
   "url": "https://clinicaltrials.gov/study/NCT06674694"
  },
  {
   "nctId": "NCT05017311",
   "briefTitle": "Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)",
   "phase": [
    "PHASE4"
   ],
   "leadSponsor": "Nova Scotia Health Authority",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-06-11",
   "startDate": "2023-01-20",
   "conditions": [
    "Major Depressive Disorder"
   ],
   "countries": [
    "Canada"
   ],
   "url": "https://clinicaltrials.gov/study/NCT05017311"
  },
  {
   "nctId": "NCT04066192",
   "briefTitle": "Brexpiprazole in Alcohol Use Disorder",
   "phase": [
    "PHASE2"
   ],
   "leadSponsor": "University of Colorado, Denver",
   "overallStatus": "RECRUITING",
   "lastUpdatePostDate": "2026-05-01",
   "startDate": "2020-10-30",
   "conditions": [
    "Alcohol Use Disorder"
   ],
   "countries": [
    "United States"
   ],
   "url": "https://clinicaltrials.gov/study/NCT04066192"
  }
 ],
 "query": {
  "intr": "brexpiprazole",
  "filterOverallStatus": "RECRUITING",
  "filterAdvanced": "AREA[StudyType]INTERVENTIONAL",
  "sort": "LastUpdatePostDate:desc",
  "apiVersion": "2.0.5"
 },
 "attribution": "ClinicalTrials.gov",
 "dataProcessedByRegistry": "2026-11-06T10:00:05",
 "modifications": "Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited."
}

SHA-256 of the exact stored value: fae6071e0cbb1dc7460285aa2eeb8265d03c449782c0e7e5c612656b88f99e18.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.